Proietti, C., Rosemblit, C., Beguelin, W., Rivas, M., Flaqué, M., Charreau, E., . . . Elizalde, P. Activation of Stat3 by heregulin/ErbB-2 through the co-option of progesterone receptor signaling drives breast cancer growth.
Cita Chicago Style (17a ed.)Proietti, C.J, C. Rosemblit, W. Beguelin, M.A Rivas, M.C.D Flaqué, E.H Charreau, R. Schillaci, y P.V Elizalde. Activation of Stat3 by Heregulin/ErbB-2 Through the Co-option of Progesterone Receptor Signaling Drives Breast Cancer Growth.
Cita MLA (8a ed.)Proietti, C.J, et al. Activation of Stat3 by Heregulin/ErbB-2 Through the Co-option of Progesterone Receptor Signaling Drives Breast Cancer Growth.
Precaución: Estas citas no son 100% exactas.